Abstract:Objective To explore the detailed underlying molecular and signaling mechanisms in the effects of icariin on bone formation by an in vitro cell model. Methods The proliferation of MC3T3-E1 osteoblast-like cells was evaluated by MTT, and gene expression of cell cycle related proteins in MC3T3-E1 cells after icariin treatment was detected by real-time PCR. The phosphorylation of MAPK signals, including ERK, P38, and JNK was determined by Western blot, and then the inhibitors of MAPK signals were used to treat cells with icariin alone or together to determine the role of MAPKs in the process of icariin treatment on MC3T3-E1 cell proliferation. Alkaline phosphatase and Alizarin red staining were used to detect the formation of mineralization nodules, and gene expressions of alkaline phosphatase, type Ⅰ collagen, and osteocalcin in osteoblasts after being treated by icariin were evaluated by real-time PCR. ICI182780, and nilutamide was used to decide the participation of estrogen and androgen receptor signals in the process of icariin treatment on the differentiation and mineralization of MC3T3-E1 cells. Results Treatment with icariin promoted MC3T3-E1 cell growth in a time- and dose-dependent manner. This treatment also revealed that icariin increased the expression of mRNAs encoding both cyclin E and PCNA, positive regulators of cell growth, but decreased levels of mRNAs encoding Cdkn2b, a negative regulator of cell cycle progression. When MC3T3-E1 cells were cultured in a differentiated condition, icariin enhanced mineralized nodule formation and increased the expression of mRNAs encoding alkaline phosphatase, type Ⅰ collagen, and osteocalcin. Treatment with icariin significantly induced phosphorylation of both ERK and JNK and this phosphorylated effect occurred very rapidly within 5 minutes and reached peak at 15 minutes. Furthermore, the stimulated effects of icariin on proliferation and gene expression of cyclin E, PCNA, and Cdkn2b in MC3T3-E1 cells were dramatically attenuated by treatment with both U0126 and SP600125, inhibitors of MAPKs. Interestingly, such stimulating effects of icariin were at least partly reduced by treatment with ICI182780, an inhibitor of estrogen receptor. Icariin induced mineralized nodule formation and gene expression of alkaline phosphatase, type Ⅰ collagen, and osteocalcin in MC3T3-E1 cells were also partly reduced when the cells were treated with ICI182780. Conclusions Our findings indicate that the anabolic effect of icariin on bone formation is, at least partly, mediated through the MAPK signaling pathway in order to modulate osteoblast proliferation and differentiation.

Icaritin and Its Glycosides Enhance Osteoblastic, but Suppress Osteoclastic, Differentiation and Activity in Vitro

Icariine Stimulates Proliferation and Differentiation of Human Osteoblasts by Increasing Production of Bone Morphogenetic Protein 2.

Comparative study on the osteogenic differentiation effects of icariin and icariside Ⅰ in rat bone marrow stromal cells

Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation

Effects of Icariin on the Differentiation and Bone-Resorption Function of Osteoclasts

Icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2

Icaritin, a Novel Plant-Derived Osteoinductive Agent, Enhances the Osteogenic Differentiation of Human Bone Marrow- and Human Adipose Tissue-Derived Mesenchymal Stem Cells.

A Novel Semisynthetic Molecule Icaritin Stimulates Osteogenic Differentiation And Inhibits Adipogenesis Of Mesenchymal Stem Cells

Icariin stimulates osteogenic differentiation and suppresses adipogenic differentiation of rBMSCs via estrogen receptor signaling.

Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner

Osteogenic Potential of Icariin Compared with Recombinant Human Bone Morphogenetic Protein 2 in Vitro: A Preliminary Study

Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.

The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice

Icariin Inhibits RANKL-induced Osteoclastogenesis Via Modulation of the NF-κB and MAPK Signaling Pathways.

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression

Antiosteoporotic Effect of Icariin in Ovariectomized Rats is Mediated Via the Wnt/β-catenin Pathway

Effect of icariin and curculigoside on inhibition of osteoclastic formation,differentiation and bone absorption

Icariin stimulates differentiation of bone marrow-derived mesenchymal stem cells (BM-MSCs) through activation of cAMP/PKA/CREB

Icariin Stimulates Osteogenic Differentiation of Rat Bone Marrow Stromal Stem Cells by Increasing TAZ Expression.

Icariin induced proliferation and differentiation of MC3T3-E1 osteoblasts via ERK and JNK signaling coupled with estrogen receptor

Icariin Regulates the Osteoblast Differentiation and Cell Proliferation of MC3T3-E1 Cells Through Microrna-153 by Targeting Runt-related Transcription Factor 2